Skip to main content

Multiple Myeloma Expanded Access to Idecabtagene Vicleucel

Status: Coming Soon

Study Details

View study details on clinicaltrials.gov.

Locations

  • Berkeley
  • Sacramento

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Expanded Access Protocol (EAP) for Patients Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release

Elias Nicolas Kiwan
Elias Nicolas Kiwan
Principal investigator
View Profile
Oleg I. Krijanovski
Oleg I. Krijanovski
Principal investigator
View Profile

Co-investigator

Kevin B Knopf

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?